Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Advertisement
Set Alert for Articles By David Ridley

Latest From David Ridley

Winter Is Coming: CHC Firms Battle It Out In Germany’s Crowded Cough And Cold Market

Consumer healthcare firms large and small will fight it out this winter for dominance in Germany's OTC cough and cold market. 
Health Launches

Patience Wins The Race: TTS Pharma's CEO On Bringing The First Legal CBD Oil To The UK Market

TTS Pharma wants to be the first to launch a legal CBD oil onto the UK wellness market. TTS CEO Mark Tucker explains how his firm's CBD is produced according to strict standards and can provide a model for future regulation. 
Wellness Dietary Supplements

RB Targets UK’s Hedonistic ‘Generation Z’ With Ironic Gaviscon Campaign

Reckitt Benckiser extends its "Night Labs" Gaviscon campaign aimed at UK 20-something heartburn sufferers with two new tongue in cheek videos.
Health OTC Drugs

UK Rx-To-OTC Switch Incubator Gets Angel Investment Boost

UK start-up Maxwellia's "switch-in-a-box" pipeline receives a boost with BioCity angel investment. 
Health OTC Drugs

Sanofi’s Alan Main On Tapping Into Millennials' Self-Care Demand

Wellness, access to credible information from healthcare professionals, and convenience are the three most important considerations of millennials when approaching self-care solutions, says Sanofi's Alan Main. By embracing smart technology, e-commerce, data-led solutions such as video consultations and new, innovative products, industry can seize the opportunity provided by this new generation of health-conscious, tech-savvy consumers.

Health Market Intelligence

British Femtech Firm 'Tackling The Silence' Surrounding Women’s Incontinence With Surreal Animations

British Femtech firm Elvie is using quirky animations to tackle taboos surrounding female incontinence and to advertise its pelvic floor trainer as an innovative wellness solution to this widespread but not talked about health issue.
Wellness OTC Devices
See All
Advertisement
UsernamePublicRestriction

Register